Navigation Links
Repligen in Medical News

Repligen Licenses Patent Rights for Treatment of Bipolar Disorder

...WALTHAM, Mass., March 31 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) announced today that...rogram of any private, U.S. psychiatric hospital. repligen is developing RG2417, an oral formulation of uridi... Herlihy, President and Chief Executive Officer of repligen Corporation. "Treatment of the symptoms of bipola...

Repligen Announces ISO 9001:2000 Certification

... WALTHAM, Mass., Feb. 12 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ), a global leader in ...lated services underlying its Protein A business. repligen has supplied Protein A products to the biopharmace...ent and Chief Executive Officer of Repligen. repligen is the world's leading supplier of recombinant Pro...

Repligen Reports Second Quarter Fiscal Year 2009 Financial Results

... WALTHAM, Mass., Nov. 6 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) today reported result... Herlihy, President and Chief Executive Officer of repligen Corporation. "As of September 30th, we had $65 mil...cologic, toxicologic and pharmacodynamic profiles. repligen announced receipt of a $1 million research grant f...

Repligen Initiates Phase 2b Clinical Trial of RG2417 in Bipolar Disorder

... WALTHAM, Mass., Nov. 6 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) announced today that ...d relapse remain common clinical problems. About repligen Corporation repligen Corporation is a biopharmaceutical company focused...

Repligen Announces Conference Call of Second Quarter Fiscal Year 2009 Results Thursday, November 6th, 10:00 a.m. EST

... WALTHAM, Mass., Oct. 30 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) announced today that ... be accessed at http://www.repligen.com . About repligen Corporation repligen Corporation is a biopharmaceutical company focused...

Compound Reverses Huntington's Symptoms in Mice

...published this week in the early edition of the Proceedings of the National Academy of Sciences . The study received funding from Massachusetts-based repligen Corp., which holds several patent applications related to HDAC (histone deacetylase) inhibitors, a class of agents that include HDACi 4b. Other HDA...

Repligen Elects Alfred L. Goldberg, Ph.D. to the Board of Directors

... WALTHAM, Mass., July 1 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) announced today that ... Herlihy, President and Chief Executive Officer of repligen Corporation. "Fred's expertise and relationships w...es and is an inventor on numerous patents. About repligen Corporation ...

Repligen Announces Share Repurchase Program

... WALTHAM, Mass., June 18 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) today announced that ...,000 shares of its common stock. Under the program repligen may repurchase shares from time to time at prevail... Herlihy, President and Chief Executive Officer of repligen Corporation. "Our strong financial position will a...

Repligen Announces Conference Call to Update Orencia(R) Lawsuit

... be accessed at http://www.repligen.com . About repligen Corporation repligen Corporation is a biopharmaceutical company focused...lings with the Securities and Exchange Commission. repligen assumes no obligation to update any forward-lookin...

Repligen Elects Earl Henry, M.D. to the Board of Directors

... WALTHAM, Mass., Dec. 13 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) announced today that ... Herlihy, President and Chief Executive Officer of repligen Corporation. "Earl's strategic guidance and relati...rovider of clinical outsourcing solutions. About repligen Corporation ...
Repligen in Medical Technology

Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications

...Schimmel has also been the co-founder or founding director of numerous successful biotechnology companies, including Sirtris Pharmaceuticals, Alnylam, repligen Corporation, Alkermes, Inc., Momenta Pharmaceuticals and Cubist Pharmaceuticals, which were taken public on the NASDAQ and are well established as com...

Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer

...ing drugs to treat inherited and acquired energy impairment diseases. Dr. Rioux' three-decade career includes industry experience at companies such as repligen Corp., Arrow International, Variagenics, Inc., Biogen and GRP (Groupement de Recherche en Pharmacologie). He previously was a researcher in Clinical R...

Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder

... WALTHAM, Mass., June 12 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) today announced that ...ill be the Principal Investigator of this study. repligen previously reported positive initial results from ...d over $200 million in funding since 1989. About repligen Corporation ...

Repligen Receives FDA Fast Track Designation for RG1068 for Pancreatic Imaging

...WALTHAM, Mass., April 16 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) announced today that ... Herlihy, President and Chief Executive Officer of repligen Corporation. "We expect to complete patient enroll...s year and, if successful, file an NDA in 2009." repligen is currently conducting a Phase 3 clinical trial t...

Repligen Initiates Phase 3 Clinical Trial of RG1068 for Pancreatic MRI Imaging

...WALTHAM, Mass., March 26 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) announced today that ... Herlihy, President and Chief Executive Officer of repligen Corporation. "There are approximately 150,000 panc...t could benefit from enhancement with secretin." repligen previously conducted a multi-center, baseline-cont...

Repligen Reports Positive Phase 2a Clinical Trial Results of RG2417 for Symptoms of Bipolar Disorder

... WALTHAM, Mass., Nov. 8 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) today announced posit... Herlihy, President and Chief Executive Officer of repligen Corporation. "The results of this study support fu...ed over $200 million in funding since 1989. About repligen Corporation ...

Repligen Reports Positive Phase 2 Clinical Trial Results of Secretin for MRI Imaging of the Pancreas

... of Orphan Products Development of the FDA granted repligen orphan drug designation for RG1068, synthetic huma...of the pancreas. Orphan drug designation qualifies repligen for seven years of exclusive marketing rights in t...or RG1068 for MRI imaging of the pancreas. About repligen Corporation ...
Repligen in Biological Technology

Repligen Reports First Quarter Fiscal Year 2010 Financial Results

... WALTHAM, Mass., Aug. 6 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) today reported resul... Herlihy, President and Chief Executive Officer of repligen Corporation. "Our financial resources will allow ...ge in Bipolar Disorder scale (CGI-BP-C). In March, repligen exclusively licensed worldwide rights to a patent ...

Repligen Announces Conference Call of First Quarter Fiscal Year 2010 Results

... WALTHAM, Mass., July 30 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) announced today that...e accessed at www.repligen.com . About repligen Corporation repligen Corporation is a biopharmaceutical company focused...

Repligen Reports Fourth Quarter and Fiscal Year 2009 Financial Results

... WALTHAM, Mass., June 11 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) today reported resul... Herlihy, President and Chief Executive Officer of repligen Corporation. "Over the next twelve months, we wil...DRS (p=0.01) and the CGI-BP-C (p=0.04). In March, repligen exclusively licensed worldwide rights to a patent ...

Repligen Announces Conference Call of Fourth Quarter and Fiscal Year 2009 Results

... WALTHAM, Mass., June 4 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) announced today that... be accessed at www.repligen.com . About repligen Corporation repligen Corporation is a biopharmaceutical company focused...

Repligen to Present at the Cowen and Company 29th Annual Healthcare Conference Monday, March 16th, 2:25 p.m. EDT

... WALTHAM, Mass., March 9 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) announced today that...or 30 days following the presentation. About repligen Corporation repligen Corporation is a biopharmaceutical company focused...

Repligen Reports Third Quarter Fiscal Year 2009 Financial Results

... WALTHAM, Mass., Feb. 5 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) today reported resul... Herlihy, President and Chief Executive Officer of repligen Corporation. "Our financial resources will allow ...s. Stock Repurchase Program In June 2008, repligen announced that its Board of Directors authorized t...

Repligen to Present at the BIO CEO & Investor Conference Monday, February 9th, 11:30 a.m. EST

... WALTHAM, Mass., Feb. 2 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) announced today that...or 30 days following the presentation. About repligen Corporation repligen Corporation is a biopharmaceutical company focused...

Repligen Announces Conference Call of Third Quarter Fiscal Year 2009 Results

... WALTHAM, Mass., Jan. 29 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) announced today that...ay be accessed at www.repligen.com . About repligen Corporation repligen Corporation is a biopharmaceutical company focused...

Repligen to Present at the Rodman & Renshaw 10th Annual Healthcare Conference Monday, November 10th, 4:55 p.m. EST

... WALTHAM, Mass., Nov. 3 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) announced today that ...ed for 30 days following the presentation. About repligen Corporation repligen Corporation is a biopharmaceutical company focused...

Repligen to Present at the 2008 UBS Global Life Sciences Conference Wednesday, September 24th, 1:00 p.m. EDT

...WALTHAM, Mass., Sept. 17 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) announced today that ...ed for 30 days following the presentation. About repligen Corporation repligen Corporation is a biopharmaceutical company focused...
Repligen in Biological Dictionary

Affymetrix

...t news headlines at MainStreet.com Research AFFYMETRIX INC historical prices, historical volume, splits and dividends. ... Orexigen Therapeutics, repligen and Affymetrix lead small-cap volume in ... Affymetrix to Host Conference Call on July 22, 2009 to Announce Second Quarter 2009 Results ... Af...
Other Tags
(Date:8/29/2015)... ... ... Dr. Tim Novelli, DC., Founder and President of the Patriot Project, is ... chiropractic field in the military. All too often VA hospitals treat patients with harmful ... to the VA program over a decade ago, the reality is that only 10% ...
(Date:8/29/2015)... ... August 29, 2015 , ... People ... pulmonary disease (including emphysema), or asthma, are at higher risk from wildfire smoke ... attack, heart failure or heart-rhythm problems (arrhythmia or irregular heartbeat) are also sensitive ...
(Date:8/28/2015)... ... August 29, 2015 , ... Rio Salado College ... the student experience as part of the EDUCAUSE - Next Generation Learning Challenges 2015 ... This is the third Breakthrough Models Incubator hosted by EDUCAUSE and NGLC, ...
(Date:8/28/2015)... ... August 28, 2015 , ... The Kentucky State Department of Workforce ... the position they are applying for, they are unable to pass the initial drug ... altering drug testing policies in order to be able to hire long-term, skilled talent. ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... Medical Devices:, Understanding the FDA’s Position and Best Practices for Compliance, **Presented ... , This workshop, chaired by internationally renowned expert Fubin Wu, has ...
Breaking Medicine News(10 mins):Health News:The Patriot Project brings Chiropractic Care to the Armed Forces and their Families - Rapid Release Technology Joins the Effort to Recruit more Doctors to Pledge 2Health News:Heart Fit Clinic Sounds the Alarm on Forest Fire Smoke and Chronic Heart Disease in Calgary Area 2Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 2Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 3Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 4Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 2Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 3Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 4Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 2Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 3Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 4Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 5
(Date:8/25/2015)... LAKE CITY and BELLEVUE, Wash. ... global leader in advanced robotic systems, announced today it ... robotic unmanned ground vehicle (UGV), at the National Tactical ... City.  The Guardian S is the ... the culmination of years of research and in-field trials ...
(Date:8/20/2015)... Calif. , Aug. 20, 2015   ... focused on improving the user experience and security ... vision technologies, today announced that its TrulySecure™ ... biometric authentication software to be FIDO Certified™. ... TrulySecure for compliance with the FIDO UAF (Universal ...
(Date:8/18/2015)... Research and Markets ( http://www.researchandmarkets.com/research/9dmm6l/global_biometric ) ... Biometric Authentication & Identification Market: Focus On Modality, ... report to their offering. ... is expected to grow at an estimated CAGR ... over $25 billion (approximately) by 2020 as per ...
Breaking Biology News(10 mins):Sarcos to Debut First-of-its-Kind Snake Robot 2Sarcos to Debut First-of-its-Kind Snake Robot 3TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 2TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 3TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 4TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 5Global Biometric Authentication & Identification Market 2015: Focus On Modality, Motility & Application - Estimation & Forecasts to 2020 for the $25 Billion Industry 2
Other Contents